AKT1 and breast carcinoma: OGN can reverse EMT through the PI3K/Akt/mTOR pathway in breast cancer [22], and reduce the expression of ZEB-1 through the EGFR/Akt signaling pathway in colon cancer to inhibit EMT [21].